NITIN RAJHANS: Open Payments
NPI 1316154156 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $29 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 1 | $110 |
| Luye Pharma (USA) Ltd. | 1 | $71 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, UZEDY.
Industry payments across MI — which companies pay providers there.
